There is a clear need for a deeper understanding of signaling pathways in GBM, which we have previously achieved using mouse models where driver signaling events (e.g., EGFR) are fully controlled (Zhu et al, 2009; Acquaviva et al, 2011; Jun et al, 2012). The gene discussed is EGFR; the disease is glioblastoma.